Survival and dosimetric parameters in stage III NSCLC patients undergoing radical chemoradiotherapy

I. Remmerts De Vries; M. Ronden; P. De Haan; F. Spoelstra; N. Haasbeek; M. Dahele; I. Bahce; S. Senan; W. Verbakel

Survival and dosimetric parameters in stage III NSCLC patients undergoing radical chemoradiotherapy

I. Remmerts De Vries, M. Ronden, P. De Haan, F. Spoelstra, N. Haasbeek, M. Dahele, I. Bahce, S. Senan, W. Verbakel

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S1046-S1046
Journal	Radiotherapy and oncology
Volume	152
Publication status	Published - Nov 2020

Cite this

@article{34d8d66334c142b18634962ceca44f9f,

title = "Survival and dosimetric parameters in stage III NSCLC patients undergoing radical chemoradiotherapy",

author = "{De Vries}, {I. Remmerts} and M. Ronden and {De Haan}, P. and F. Spoelstra and N. Haasbeek and M. Dahele and I. Bahce and S. Senan and W. Verbakel",

year = "2020",

month = nov,

language = "English",

volume = "152",

pages = "S1046--S1046",

journal = "Radiotherapy and oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Survival and dosimetric parameters in stage III NSCLC patients undergoing radical chemoradiotherapy

AU - De Vries, I. Remmerts

AU - Ronden, M.

AU - De Haan, P.

AU - Spoelstra, F.

AU - Haasbeek, N.

AU - Dahele, M.

AU - Bahce, I.

AU - Senan, S.

AU - Verbakel, W.

PY - 2020/11

Y1 - 2020/11

M3 - Meeting Abstract

SN - 0167-8140

VL - 152

SP - S1046-S1046

JO - Radiotherapy and oncology

JF - Radiotherapy and oncology

ER -